New bill proposes central licensing for some critical drugs
Licences for manufacturing drugs under 17 critical categories will be given only by the Centre and not by states, a […]
Say something
Licences for manufacturing drugs under 17 critical categories will be given only by the Centre and not by states, a […]
The increased risk of heart attack or stroke associated with many arthritis drugs may be avoidable, according to a new […]
In a major setback to pharmaceutical companies, the Supreme Court today held that asthma medicine Doxofylline is a bulk drug […]
In the wake of a government ban on top-selling diabetes drug, pioglitazone, the volumes are expected to shift to other […]
Begining this October, Indian students interested in Public Health will have an opportunity to join a prestigious international post-graduate programme […]
By- Dr V K Singh Healthcare delivery is a nightmare and challenge for health planners in every country may it […]
Dassault Systèmes, the 3DEXPERIENCE Company, a world leader in 3D design, 3D Digital Mock Up and Product Lifecycle Management […]
The UN drug control agency on Wednesday sounded the alarm on the spread of designer drugs, which are sold openly […]
The US National Institutes of Health said on Wednesday it is reducing the number of chimpanzees it uses in biomedical […]
After two of the country’s top drug makers ran into trouble with US Food and Drug Administration (USFDA), the Drug […]
The Global Indian of the Year 2013 Award was conferred on renowned homeopath Dr Mukesh Batra, Founder-Chairman, Dr Batras, at […]
The Union Health Ministry has suspended the sale of two drugs – painkiller Analgin and anti-diabetes drug Pioglitazone and all […]
Building upon its success delivering solutions that operationalize predictive analytics for key vertical markets, such as banking, financial services, retail […]